Natco Pharma Ltd.
| BSE: 524816 | Sector: Health care |
| NSE: NATCOPHARM | ISIN Code: INE987B01026 |
| BSE 00:00 | 26 Feb | 812.60 |
10.40 (1.30%) |
OPEN
815.00 |
HIGH
820.00 |
LOW
795.10 |
| NSE 00:00 | 26 Feb | 811.35 |
9.05 (1.13%) |
OPEN
803.55 |
HIGH
820.00 |
LOW
793.20 |
| OPEN | 815.00 |
| PREVIOUS CLOSE | 802.20 |
| VOLUME | 24501 |
| 52-Week high | 995.05 |
| 52-Week low | 450.00 |
| P/E | 41.93 |
| Mkt Cap.(Rs cr) | 14,818 |
| Buy Price | 809.00 |
| Buy Qty | 4.00 |
| Sell Price | 812.60 |
| Sell Qty | 5.00 |
Natco Pharma Ltd. (NATCOPHARM) - Corporate Action
| ANNOUNCEMENT DATE | PURPOSE | EGM DATE | REMARKS |
| 29-11-2017 | EGM | 29-11-2017 | outcome of the EGM and MinutesOutcome of Extraordina... |
| 22-05-2015 | EGM | 27-06-2015 | EGM 27.06.2015Natco Pharma Ltd has informed BSE that... |
| 19-10-2013 | EGM | 14-11-2013 | Natco Pharma Ltd has informed BSE that the Board of ... |
Quick Links for Natco Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
